178 related articles for article (PubMed ID: 32236893)
1. iRhom2 in the pathogenesis of oral squamous cell carcinoma.
Agwae ME; Shaw RJ; Triantafyllou A; Greaney FST; Ben Salah K; Risk JM
Mol Biol Rep; 2020 May; 47(5):3987-3992. PubMed ID: 32236893
[TBL] [Abstract][Full Text] [Related]
2. Low expression of lncRNA MEG3 promotes the progression of oral squamous cell carcinoma by targeting miR-21.
Zhang LL; Hu D; Zou LH
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8315-8323. PubMed ID: 30556872
[TBL] [Abstract][Full Text] [Related]
3. ADAM17 stabilizes its interacting partner inactive Rhomboid 2 (iRhom2) but not inactive Rhomboid 1 (iRhom1).
Weskamp G; Tüshaus J; Li D; Feederle R; Maretzky T; Swendemann S; Falck-Pedersen E; McIlwain DR; Mak TW; Salmon JE; Lichtenthaler SF; Blobel CP
J Biol Chem; 2020 Mar; 295(13):4350-4358. PubMed ID: 32060096
[TBL] [Abstract][Full Text] [Related]
4. CD47-SIRPα Signaling Induces Epithelial-Mesenchymal Transition and Cancer Stemness and Links to a Poor Prognosis in Patients with Oral Squamous Cell Carcinoma.
Pai S; Bamodu OA; Lin YK; Lin CS; Chu PY; Chien MH; Wang LS; Hsiao M; Yeh CT; Tsai JT
Cells; 2019 Dec; 8(12):. PubMed ID: 31861233
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-504 functions as a tumor suppressor in oral squamous cell carcinoma through inhibiting cell proliferation, migration and invasion by targeting CDK6.
Wang X; Chang K; Gao J; Wei J; Xu G; Xiao L; Song G
Int J Biochem Cell Biol; 2020 Feb; 119():105663. PubMed ID: 31812760
[TBL] [Abstract][Full Text] [Related]
6. The serum biomarker chemerin promotes tumorigenesis and metastasis in oral squamous cell carcinoma.
Lu Z; Liang J; He Q; Wan Q; Hou J; Lian K; Wang A
Clin Sci (Lond); 2019 Mar; 133(5):681-695. PubMed ID: 30804218
[TBL] [Abstract][Full Text] [Related]
7. Pathobiological role of cleft palate transmembrane protein 1 family proteins in oral squamous cell carcinoma.
Inoue K; Hatano K; Hanamatsu Y; Saigo C; Kito Y; Bunai K; Shibata T; Takeuchi T
J Cancer Res Clin Oncol; 2019 Apr; 145(4):851-859. PubMed ID: 30635792
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
[TBL] [Abstract][Full Text] [Related]
9. Association of iRhom1 and iRhom2 expression with prognosis in patients with cervical cancer and possible signaling pathways.
Xu Q; Chen C; Liu B; Lin Y; Zheng P; Zhou D; Xie Y; Lin Y; Guo C; Liu J; Li L
Oncol Rep; 2020 Jan; 43(1):41-54. PubMed ID: 31661139
[TBL] [Abstract][Full Text] [Related]
10. LncRNA MINCR activates Wnt/β-catenin signals to promote cell proliferation and migration in oral squamous cell carcinoma.
Lyu Q; Jin L; Yang X; Zhang F
Pathol Res Pract; 2019 May; 215(5):924-930. PubMed ID: 30777615
[TBL] [Abstract][Full Text] [Related]
11. MiR-127-3p targets KIF3B to inhibit the development of oral squamous cell carcinoma.
Ji L; Zhu ZN; He CJ; Shen X
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):630-640. PubMed ID: 30720171
[TBL] [Abstract][Full Text] [Related]
12. Involvement of RNase 7 in the malignant potential of oral squamous cell carcinoma cells.
Neopane P; Kurashige Y; Yoshida K; Uehara O; Paudel D; Morikawa T; Sato J; Saitoh M; Abiko Y
Oncol Rep; 2020 Sep; 44(3):1216-1223. PubMed ID: 32705284
[TBL] [Abstract][Full Text] [Related]
13. Cancer‑associated fibroblast‑derived exosomal miR‑382‑5p promotes the migration and invasion of oral squamous cell carcinoma.
Sun LP; Xu K; Cui J; Yuan DY; Zou B; Li J; Liu JL; Li KY; Meng Z; Zhang B
Oncol Rep; 2019 Oct; 42(4):1319-1328. PubMed ID: 31364748
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA LINC01133 inhibits oral squamous cell carcinoma metastasis through a feedback regulation loop with GDF15.
Kong J; Sun W; Zhu W; Liu C; Zhang H; Wang H
J Surg Oncol; 2018 Dec; 118(8):1326-1334. PubMed ID: 30332510
[TBL] [Abstract][Full Text] [Related]
15. MiR-373 promotes proliferation and metastasis of oral squamous cell carcinoma by targeting SPOP.
Zhang XJ; Jin Y; Song JL; Deng F
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5270-5276. PubMed ID: 31298378
[TBL] [Abstract][Full Text] [Related]
16. Function and transcriptional regulation of TCTN1 in oral squamous cell carcinoma.
Bai G; Wei N; Li F; Zhao P; Meng Z; Zou B; Liu Y; Xu K; Li K; Yao C; Yang P
Oncol Rep; 2022 Feb; 47(2):. PubMed ID: 34859261
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of ROS/NUPR1-dependent autophagy antagonises repeated cadmium exposure -induced oral squamous cell carcinoma cell migration and invasion.
Fan T; Chen Y; He Z; Wang Q; Yang X; Ren Z; Zhang S
Toxicol Lett; 2019 Oct; 314():142-152. PubMed ID: 31319114
[TBL] [Abstract][Full Text] [Related]
18. iRhom2 regulates ERBB signalling to promote KRAS-driven tumour growth of lung cancer cells.
Sieber B; Lu F; Stribbling SM; Grieve AG; Ryan AJ; Freeman M
J Cell Sci; 2022 Sep; 135(17):. PubMed ID: 35971826
[TBL] [Abstract][Full Text] [Related]
19. iRhom2: An Emerging Adaptor Regulating Immunity and Disease.
Al-Salihi MA; Lang PA
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911849
[TBL] [Abstract][Full Text] [Related]
20. Mechanistic insight on the role of iRhom2-TNF-α-BAFF signaling pathway in various autoimmune disorders.
Dwivedi SD; Shukla R; Yadav K; Rathor LS; Singh D; Singh MR
Adv Biol Regul; 2024 May; 92():101011. PubMed ID: 38151421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]